Safety and Efficacy of TD0025 (Rocket1h) for Treatment of Erectile Dysfunction
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify the optimal dose(s) of TD0025 for treatment of
erectile dysfunction (phase II) and to investigate if treatment of erectile dysfunction with
the optimal dose of TD0025 taken as needed over one month is non-inferior than Sildenafil
Citrate taken as needed over one month (phase III)